Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 5/2006

01-05-2006 | Case Reports

Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement

Authors: María González Cao, Gorka Bastarrika, Jesús García-Foncillas, Javier Aristu, Ana Chopitea, Salvador Martín Algarra

Published in: Clinical and Translational Oncology | Issue 5/2006

Login to get access
Metadata
Title
Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement
Authors
María González Cao
Gorka Bastarrika
Jesús García-Foncillas
Javier Aristu
Ana Chopitea
Salvador Martín Algarra
Publication date
01-05-2006
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 5/2006
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-006-0184-8

Other articles of this Issue 5/2006

Clinical and Translational Oncology 5/2006 Go to the issue

Editorial

Stem cells: promises and realities in cancer research

Research Articles

Cosmetic outcome of breast conservative treatment for early stage breast cancer

Research Articles

Lack of correlation between DNA copy number and mRNA expression levels ofc-myc in γ-radiation-induced mouse thymic lymphomas by using quantitative real-time PCR

Original Articles

Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer

Case Reports

Primary hormone treatment in postmenopausal women with breast cancer

Review

Cutaneous metastases of lung cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits